heart transplantation

Development of abdominal heart transplantation model by cuff technique in rats

套管连接法在大鼠心脏腹部移植模型中的应用

Objectives: Heart transplantation has become the most effective therapy for end-stage heart disease.

背景与目的：心脏移植已成为治疗终末期心脏病人的有效手段。

The recent study shows that TGF-1, can antagonize allograft rejection, and the application of TGF-P jto the allogeneic heart transplantation and pancreas islet cell transplantation model in the mice and rats can significantly prolong the allograft survival.

近、－来研究发现，TGF民能够对抗免疫排斥反应，在小鼠及大鼠同种异体心脏移植及－。胰岛细胞移植模型中应用TGF－民能够明显延长移植物存活时间。

Methods Eighty animal models were made. In animal models of heterotopic heart transplantation from Wistar to SD rats, we improved greatly on donor cardiectomy, heparinization of recipient, preparation of celiac vessel, vascular anastomosis, myocardial perfusion and protection.

方法：制作80例Wistar SD大鼠腹腔异位心脏移植动物模型，在供心的切取、受体的肝素化、腹腔血管的准备、心肌的灌注和保护及血管的吻合上有较多的改进。

Heart transplantation for end-stage dilated cardiomyopathy in children: Case report

心脏移植治疗儿童晚期扩张型心肌病一例报告

Related risk factor of allograft coronary artery disease after heart transplantation

心脏移植术后冠状动脉病变的相关因素分析

Methods Clinical data of 32 cases of coronary artery disease after heart transplantation were reviewed.

方法回顾性分析32例心脏移植术后长期存活患者的临床资料，并对相关的临床因素进行评价，筛选出移植心冠状动脉病变的独立危险因素。

Background: The allograft heart transplantation has been developed to become an effective therapy for terminal heart disease.

背景及目的：经过多年基础研究和临床实验，同种原位心脏移植已成为一种应用于临床治疗终末期心脏病的有效方法。

Objective To introduce the experience of heart transplantation in a 52 days old infant with hypoplastic left heart syndrome ( HLHS).

【目的】报告1例左心发育不全综合征52d婴幼儿进行原位心脏移植的临床经验。

The Experimental Study of the Treatment of the Decoy Double-strand Oligonucleotides for NF-kB in Rat Heart Transplantation

NF-kB诱饵双链核苷酸在大鼠心脏移植中作用的实验研究

Objective To summarize the experience of donor heart preservation in heart transplantation.

目的总结同种异体心脏移植供心保护经验。

Therapeutic drug monitoring of cyclosporin-A after the first heart transplantation in GUANGXI

广西首例心脏移植术后环孢素A的药物监测

Further research is needed to define the optimal organ-allocation system for pediatric heart transplantation.

我们仍应进一步地研究探索最佳的儿科心脏移植的器官分配系统.

From April 1992 to November 1995, we successfully performed orthotopic heart transplantation ( OHT) in 3 patients with late stage cardiomyopathy.

1992年4月至1995年11月我们为3例终末期心脏病患者成功地实施了原位心脏移植。

Objective To investigate donor heart preservation by osthol injection in canine orthotopic heart transplantation.

目的探讨蛇床子素注射液在犬原位心脏移植中对供心的保护作用.

A mouse cervical heart transplantation model using a Cuff technique

应用Cuff技术建立小鼠异位心脏移植模型

Objective Heart transplantation is the unique method to cure terminal stage heart failure. However, the urgent and chronic reject reaction after heart transplantation restrict the method widely used.

目的心脏移植是临床治疗终末期心功能衰竭的唯一有效手段，但术后急、慢性排斥反应严重制约着该技术的广泛推广应用。

Methods Model of mice cervical heterotopic heart transplantation was established.

方法采用小鼠颈部心脏移植模型,随机分为3组:对照组,移植组,落新妇甙组.

Thomas solution during orthotopic heart transplantation. Contents Determination of Metronidazole and Furacilin in its Collut with HPLC Method

Thomas液。HPLC法测定复方替硝唑漱口液中替硝唑和呋喃西林的含量

Results Heterotopic heart transplantation could be developed by microsurgery scuccessfully.

结果应用显微外科技术可以建立大鼠异位心脏移植模型.

Howeer, diabetes-related complications ( DRCs ) are a relative contraindication for heart transplantation.

但是, 糖尿病相关的并发症 ( DRCs ) 是心脏移植的一类相关禁忌症.

Objective To evaluate the clinical value of the EMB by the use of color Doppler flow image ( CDFI) in heart transplantation.

目的评估心脏移植术后在多普勒超声引导下行心内膜心肌活检的应用价值。

Clinical use of endomyocardial biopsy ( EMB) after orthotopic heart transplantation

心脏移植术后心内膜-心肌活检的临床应用

Omega-3 fatty acids in cardiac biopsies from heart transplantation patients: Correlation with erythrocytes and response to supplementation

心脏移植患者心肌活检标本中ω-3脂肪酸与红细胞的相关性及对补充的反应

The Management of Extracorporeal Circulation in Heart Transplantation With Long-time Preserved Heart

供心冷缺血保存时间较长的体外循环管理

CONCLUSION Our newly established murine model of heterotopic heart transplantation is stable and reliable.

结论采用新方法可提高小鼠腹腔异位心脏移植成功率.

Objective: to explore the method and technique of eviscerating the donor heart by simulating the heart transplantation in dog according to clinical allogenic ih-situ standards.

目的：应用犬模拟临床同种异体原位标准式心脏移植，探讨供心切取的方法和技巧。

Methods: The microsurgery technique was used to develop method heterotopic heart transplantation in the rat abdomen.

方法以显微外科手术技术建立异位大鼠心脏移植模型.

Conclusion Preoperative HBV infection was not the contraindication for heart transplantation.

结论术前合并HBV感染并非心脏移植手术的绝对禁忌证，只要处理得当，就可行心脏移植，术后患者可长期存活。

Method: 4 cases with terminal stage heart disease received heart transplantation.

方法：为4例终末期心脏病患者施行标准的同种异体原位心脏移植术。